Management of Hypertension in CAKUT: Protective Factor for CKD
نویسندگان
چکیده
منابع مشابه
Masked Uncontrolled Hypertension in CKD.
Masked uncontrolled hypertension (MUCH) is diagnosed in patients treated for hypertension who are normotensive in the clinic but hypertensive outside. In this study of 333 veterans with CKD, we prospectively evaluated the prevalence of MUCH as determined by ambulatory BP monitoring using three definitions of hypertension (daytime hypertension ≥135/85 mmHg; either nighttime hypertension ≥120/70 ...
متن کاملTraditional Persian Medicine for the Management of Hypertension
Hypertension is a major risk factor for the cardiovascular diseases. One of the factors contributing to blood pressure is peripheral vascular resistance. Vascular stiffness plays a key role in developing the hypertension, leading to increased systolic blood pressure and pulse pressure. from Avicenna s perspective, the blood pressure caused by 1- Increased blood volume 2- Warm heart dystemperame...
متن کاملFloating microspheres encapsulating carvedilol for the effective management of hypertension
Carvedilol (CVD) is an antihypertensive agent with a short half-life, pH-dependent solubility, and narrow absorption window. The purpose of this research was to prepare a floating-drug delivery-system of carvedilol to increase its half-life. The present study investigates the preparation of carvedilol-floating microspheres, evaluates the floating-drug delivery-system (FDDS) (by scanning electro...
متن کاملstudy of cohesive devices in the textbook of english for the students of apsychology by rastegarpour
this study investigates the cohesive devices used in the textbook of english for the students of psychology. the research questions and hypotheses in the present study are based on what frequency and distribution of grammatical and lexical cohesive devices are. then, to answer the questions all grammatical and lexical cohesive devices in reading comprehension passages from 6 units of 21units th...
[Management of hyperphosphatemia in CKD].
2.2 Na DRC estágios III e IV, a ingestão dietética de P deverá ser mantida em valores que atendam a recomendação de proteínas entre 0,6 e 0,8 g/kg/dia, porém não superior a 700 mg/dia se o P estiver acima dos valores normais e/ou se o paratormônio (PTH) estiver acima do nível recomendado para o estágio da DRC (Opinião). 2.3 Na DRC estágio V D, a ingestão dietética de P deverá estar entre 800 e ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Pediatrics
سال: 2019
ISSN: 2296-2360
DOI: 10.3389/fped.2019.00222